Meridian Bioscience To Be Acquired By SD Biosensor, SJL Partners - Read For How Much

SD Biosensor Inc (SDB) and SJL Partners LLC have agreed to acquire Meridian Bioscience Inc VIVO in an all-cash transaction valued at approximately $1.53 billion.
Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, representing a premium of approximately 32% over the last close price before the Consortium's first offer on March 18.
The transaction is expected to close in the fourth calendar quarter of 2022.
Upon completion of the transaction, SDB will own 60%, and SJL will own 40% of Meridian, which will no longer be traded or listed on any public securities exchange.
Separately, Meridian Bioscience provided interim Q3 FY22 sales of $66 million - $69 million, against the consensus of $69.57 million.
The company expects the Diagnostics segment's sales to be $41 million - $43 million and the Life Science segment's sales to be $25 million - $26 million.
Price Action: VIVO shares are down 1.00% at $33.22 on the last check Thursday.